IQWiG raises WHO's ante on trial transparency

Germany's Institute for Quality and Efficiency in Health Care (IQWiG) applauded the proposed clinical trial transparency policy from the World Health Organization, but said the policy "does not go far enough."

The German organization made a public comment on WHO's Statement on Public Disclosure of Clinical Trial Results, issued last month. The proposed policy called for all human trials to be registered in a public database, with trial results published no later than 30 months after they are completed (see BioCentury Extra, Oct. 23). ...